Enveric Biosciences Inc. (ENVB)

Business: Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care.

IPO Date: 24-Jun-2015

Exec. Chairman: Mr. David Ian Johnson

CEO & Director: Dr. Joseph Edward Tucker Ph.D.

Listing: NASDAQ: ENVB

Country: United States

Headquarters: Naples, FL

Website: https://www.enveric.com

Market cap: $9.34 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-50.25 Mln

Cash: $21.69 Mln

Total Debt: $0.15 Mln

Insider's Holding: 26.87%

Liquidity: Low

52 Week range: $5.90 - 187.00

Shares outstanding: 1,286,540

10 Years Aggregate:

• CFO: $-29.57 Mln
• EBITDA: $-55.66 Mln
• Net Profit: $-92.15 Mln